ReviewClinica chimica acta; international journal of clinical chemistry2012
The evolution of biobanking best practices.
Review in Clinica chimica acta; international journal of clinical chemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
49 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The efficacy of novel biomarkers for the early detection and management of acute kidney injury: A systematic review.PloS one · 2025Pooled it
- Paediatric biobanking in the era of precision medicine: ethical, regulatory, and scientific challenges from childhood to adulthood.European journal of pediatrics · 2026Review
- Review
- Optimizing Tissue Sampling Timing for Accurate Gene Expression Analysis.International journal of molecular sciences · 2025Article
- Biorepositories For Global Rare Disease Research: A Narrative Review.Current rheumatology reports · 2025Review
- How the world of biobanking is changing with artificial intelligence.Frontiers in digital health · 2025Review
- [Next generation tissue biobanking: quality assured, financed, and integrated?]Pathologie (Heidelberg, Germany) · 2024Review
- Biobanks as an Indispensable Tool in the "Era" of Precision Medicine: Key Role in the Management of Complex Diseases, Such as Melanoma.Journal of personalized medicine · 2024Review
- Improved Biorepository to Support Sickle Cell Disease Genomics and Clinical Research: A Practical Approach to Link Patient Data and Biospecimens from Muhimbili Sickle Cell Program, Tanzania.Biopreservation and biobanking · 2024Article
- Impact of ultra-low temperature storage on serum sIgE detection and allergic disease biobank feasibility.Scientific reports · 2023Article
- Assessment of Current Practices Across Alzheimer's Disease Research Centers Biorepositories.Biopreservation and biobanking · 2023Article
- Specimen sharing for epidemic preparedness: Building a virtual biorepository system from local governance to global partnerships.PLOS global public health · 2023Article
- Bridging gaps between images and data: a systematic update on imaging biobanks.European radiology · 2022Review
- Commodification of biomaterials and data when funding is contingent to transfer in biobank research.Medicine, health care, and philosophy · 2021Review
- Dwarna: a blockchain solution for dynamic consent in biobanking.European journal of human genetics : EJHG · 2020Article
- Biobanking for Cancer Biomarker Research: Issues and Solutions.Biomarker insights · 2020Review
- Mini-Review of Laboratory Operations in Biobanking: Building Biobanking Resources for Translational Research.Frontiers in public health · 2020Review
- Morocco's First Biobank: Establishment, Ethical Issues, Biomedical Research Opportunities, and Challenges.BioMed research international · 2020Article
- Enriching Personalized Endometrial Cancer Research with the Harmonization of Biobanking Standards.Cancers · 2019Review
- Specimen Collection for Translational Studies in Hidradenitis Suppurativa.Scientific reports · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Biobanks and biospecimens are critical components for many areas of clinical and basic research. The quality of biospecimens and associated data must be consistent and collected according to standardized methods in order to prevent spurious analytical results that can lead to artifacts being interpreted as valid findings. A number of international institutions have taken the initiative to develop and publish best practices, which include technical recommendations for handling biospecimens as well as recommendations for ethical and regulatory practices in biobanking. These sources of guidance have been useful in raising the overall consistency and quality of research involving biospecimens. However, the lack of international harmonization, uneven adoption, and insufficient oversight of best practices are preventing further improvements in biospecimen quality and coordination among collaborators and biobanking networks. In contrast to the more straightforward technical and management issues, ethical and regulatory practices often involve issues that are more controversial and difficult to standardize.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.